ecancermedicalscience

ecancermedicalscience is an open access cancer journal focused on under-resourced communities. In order to help reduce global inequalities in cancer care and treatment, we provide free access to all articles from the point of publication and we only charge authors who have specific funding to cover publication costs.

The journal considers articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epidemiology, clinical reports, controlled trials (in particular if they are independent or publicly funded trials), health systems, cancer policy and regulatory aspects of cancer care.

Editor-in-Chief: Dr Eduardo Cazap, MD PhD (President SLACOM)

ISSN: 1754-6605

Submit article

521-repurposing-drugs-in-oncology-redo-itraconazole-as-an-anti-cancer-agent

Clinical Study: Repurposing Drugs in Oncology (ReDO)—itraconazole as an anti-cancer agent

Pan Pantziarka, Vidula Sukhatme, Gauthier Bouche, Lydie Meheus, Vikas P Sukhatme

15 Apr 2015

https://doi.org/10.3332/ecancer.2015.521

Abstract | Full Article | PDF

513-repurposing-drugs-in-oncology-redo-clarithromycin-as-an-anti-cancer-agent

Clinical Study: Repurposing Drugs in Oncology (ReDO)—clarithromycin as an anti-cancer agent

An MT Van Nuffel, Vidula Sukhatme, Pan Pantziarka, Lydie Meheus, Vikas P Sukhatme, Gauthier Bouche

24 Feb 2015

https://doi.org/10.3332/ecancer.2015.513

Abstract | Full Article | PDF

488-eurocan-platform-meeting-european-recommendations-for-biomarker-based-chemoprevention-trials

Conference Report: Eurocan Platform meeting: European recommendations for biomarker-based chemoprevention trials

Linda Cairns

8 Dec 2014

https://doi.org/10.3332/ecancer.2014.488

Abstract | Full Article | PDF

472-from-precision-medicine-to-cancer-care-through-the-immunome-highlights-from-the-european-society-of-medical-oncology-congress-madrid-26-30th-september-2014

Conference Report: From precision medicine to cancer care through the immunome: highlights from the European Society of Medical Oncology Congress, Madrid, 26–30th September 2014

Giuseppe Curigliano

16 Oct 2014

https://doi.org/10.3332/ecancer.2014.472

Abstract | Full Article | PDF

452-interpretation-of-pet-ct-findings-in-patients-with-advanced-lung-cancer-who-have-undergone-pleurodesis

Case Report: Interpretation of PET/CT findings in patients with advanced lung cancer who have undergone pleurodesis

Marcus Paulo Fernandes Amarante, Riad Naim Younes, Letícia Rigo, Marcelo Rocha de Sousa Cruz

12 Aug 2014

https://doi.org/10.3332/ecancer.2014.452

Abstract | Full Article | PDF | Portuguese

424-mistletoe-preparation-viscum-fraxini-2-as-palliative-treatment-of-malignant-pleural-effusion-a-feasibility-study-with-comparison-to-bleomycin

Research: Mistletoe preparation (Viscum Fraxini-2) as palliative treatment of malignant pleural effusion: a feasibility study with comparison to bleomycin

Rabab Gaafar, Abdel Rahman M Abdel Rahman, Fatma Aboulkasem, Ahmed El Bastawisy

25 Apr 2014

https://doi.org/10.3332/ecancer.2014.424

Abstract | Full Article | PDF

414-atypical-primary-pulmonary-meningioma-a-report-of-a-case-suspected-of-being-a-lung-metastasis

Case Report: Atypical primary pulmonary meningioma: a report of a case suspected of being a lung metastasis

Daniela Lepanto, Fausto Maffini, Francesco Petrella, Marzia Colandrea, Carlo Putzu, Massimo Barberis, Giovanni Paganelli, Giuseppe Viale

31 Mar 2014

https://doi.org/10.3332/ecancer.2014.414

Abstract | Full Article | PDF